BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15018739)

  • 1. Mobilized blood CD34+ cells transduced and selected with a clinically applicable protocol reconstitute lymphopoiesis in SCID-Hu mice.
    Deola S; Scaramuzza S; Birolo RS; Carballido-Perrig N; Ficara F; Mocchetti C; Dando J; Carballido JM; Bordignon C; Roncarolo MG; Bregni M; Aiuti A
    Hum Gene Ther; 2004 Mar; 15(3):305-11. PubMed ID: 15018739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of gene transfer into primitive human hematopoietic cells of granulocyte-colony stimulating factor-mobilized peripheral blood using low-dose cytokines and comparison of a gibbon ape leukemia virus versus an RD114-pseudotyped retroviral vector.
    van der Loo JC; Liu BL; Goldman AI; Buckley SM; Chrudimsky KS
    Hum Gene Ther; 2002 Jul; 13(11):1317-30. PubMed ID: 12162814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-surface marking of CD(34+)-restricted phenotypes of human hematopoietic progenitor cells by retrovirus-mediated gene transfer.
    Ruggieri L; Aiuti A; Salomoni M; Zappone E; Ferrari G; Bordignon C
    Hum Gene Ther; 1997 Sep; 8(13):1611-23. PubMed ID: 9322094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained gene expression in retrovirally transduced, engrafting human hematopoietic stem cells and their lympho-myeloid progeny.
    Cheng L; Du C; Lavau C; Chen S; Tong J; Chen BP; Scollay R; Hawley RG; Hill B
    Blood; 1998 Jul; 92(1):83-92. PubMed ID: 9639503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enrichment of human hematopoietic stem cell activity in the CD34+Thy-1+Lin- subpopulation from mobilized peripheral blood.
    Murray L; Chen B; Galy A; Chen S; Tushinski R; Uchida N; Negrin R; Tricot G; Jagannath S; Vesole D
    Blood; 1995 Jan; 85(2):368-78. PubMed ID: 7529060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo evidence for the long-term multilineage (myeloid, B, NK, and T) reconstitution capacity of ex vivo expanded human CD34(+) cord blood cells.
    Kobari L; Pflumio F; Giarratana M; Li X; Titeux M; Izac B; Leteurtre F; Coulombel L; Douay L
    Exp Hematol; 2000 Dec; 28(12):1470-80. PubMed ID: 11146169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An improved vector for high-level, consistent retroviral transgene expression in human thymocytes after competitive reconstitution from transduced peripheral blood stem cells.
    Austin TW; Moss K; Morel F; Plavec I
    Hum Gene Ther; 2001 Jul; 12(10):1239-49. PubMed ID: 11440618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of retroviral gene transduction of mobilized primitive hematopoietic progenitors by using thrombopoietin, Flt3, and Kit ligands and RetroNectin culture.
    Murray L; Luens K; Tushinski R; Jin L; Burton M; Chen J; Forestell S; Hill B
    Hum Gene Ther; 1999 Jul; 10(11):1743-52. PubMed ID: 10446914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained long-term engraftment and transgene expression of peripheral blood CD34+ cells transduced with third-generation lentiviral vectors.
    Tesio M; Gammaitoni L; Gunetti M; Leuci V; Pignochino Y; Jordaney N; Capellero S; Cammarata C; Caione L; Migliaretti G; Fagioli F; Tabilio A; Aglietta M; Piacibello W
    Stem Cells; 2008 Jun; 26(6):1620-7. PubMed ID: 18369098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained retroviral gene marking and expression in lymphoid and myeloid cells derived from transduced hematopoietic progenitor cells.
    Plavec I; Voytovich A; Moss K; Webster D; Hanley MB; Escaich S; Ho KE; Böhnlein E; DiGiusto DL
    Gene Ther; 1996 Aug; 3(8):717-24. PubMed ID: 8854097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient adenoviral vector transduction of human hematopoietic SCID-repopulating and long-term culture-initiating cells.
    Fan X; Brun A; Segrén S; Jacobsen SE; Karlsson S
    Hum Gene Ther; 2000 Jun; 11(9):1313-27. PubMed ID: 10890741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
    Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R
    Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human CD34+ hematopoietic cells transduced by retrovirus-mediated interferon alpha gene maintains regeneration capacity and engraftment in NOD/SCID mice.
    Quan S; Seiter K; Feldman E; Yang L; Argani I; Farley TJ; Abraham NG; Ahmed T
    Exp Hematol; 1999 Oct; 27(10):1511-8. PubMed ID: 10517492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient human immunodeficiency virus-based vector transduction of unstimulated human mobilized peripheral blood CD34+ cells in the SCID-hu Thy/Liv model of human T cell lymphopoiesis.
    Douglas JL; Lin WY; Panis ML; Veres G
    Hum Gene Ther; 2001 Mar; 12(4):401-13. PubMed ID: 11242532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transduced CD34+ cells from adrenoleukodystrophy patients with HIV-derived vector mediate long-term engraftment of NOD/SCID mice.
    Benhamida S; Pflumio F; Dubart-Kupperschmitt A; Zhao-Emonet JC; Cavazzana-Calvo M; Rocchiccioli F; Fichelson S; Aubourg P; Charneau P; Cartier N
    Mol Ther; 2003 Mar; 7(3):317-24. PubMed ID: 12668127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of anti-CCR5 ribozyme-transduced CD34+ hematopoietic progenitor cells in vitro and in a SCID-hu mouse model in vivo.
    Bai J; Gorantla S; Banda N; Cagnon L; Rossi J; Akkina R
    Mol Ther; 2000 Mar; 1(3):244-54. PubMed ID: 10933940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of human hematopoietic stem cell populations.
    Murray L; DiGiusto D; Chen B; Chen S; Combs J; Conti A; Galy A; Negrin R; Tricot G; Tsukamoto A
    Blood Cells; 1994; 20(2-3):364-9; discussion 369-70. PubMed ID: 7538340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High levels of transgene expression following transduction of long-term NOD/SCID-repopulating human cells with a modified lentiviral vector.
    Gao Z; Golob J; Tanavde VM; Civin CI; Hawley RG; Cheng L
    Stem Cells; 2001; 19(3):247-59. PubMed ID: 11359950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukemic burden in subpopulations of CD34+ cells isolated from the mobilized peripheral blood of alpha-interferon-resistant or -intolerant patients with chronic myeloid leukemia.
    Van den Berg D; Wessman M; Murray L; Tong J; Chen B; Chen S; Simonetti D; King J; Yamasaki G; DiGiusto R; Gearing D; Reading C
    Blood; 1996 May; 87(10):4348-57. PubMed ID: 8639795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-efficiency retroviral transduction of fetal liver CD38-CD34++ cells: implications for in utero and ex utero gene therapy.
    Ohkubo T; Bárcena A; Smith CA; Harrison MR; Muench MO
    Fetal Diagn Ther; 2001; 16(5):299-307. PubMed ID: 11509853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.